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Preparing healthy community members with timely communications prior to engaging them in a
request to donate biospecimens promises to improve the experience of biobanking participation.
To this end, a qualitative study was conducted to assess community member knowledge, attitudes,
beliefs, and informational needs about cancer-related biospecimen collection in a large
metropolitan area in southwest Florida. The study utilized purposive sampling techniques to
recruit a total of 95 participants to participate in 12 focus groups, segmented by race/ethnicity and
language preference (mixed race, African American only, and Spanish speaking) and age (18–29,
30–54, and 55 and older). Focus group interviews were analyzed using content analysis to identify
emergent themes. Overall, participants in the 30 years and older groups were favorable toward
participating in biobanking if their concerns were addressed, such as confidentiality and consent
issues, in contrast to participants aged 18–29 who were more skeptical. For all participants, the
desire to participate in research that seeks new cancer treatments outweighed mistrust. Moreover,
many cited the potential scientific benefit for future generations as a primary motivator. Finally, in
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some groups a therapeutic misconception was expressed, where participants expressed a
willingness to forego confidentiality of their health status in exchange for therapeutic benefit. This
study contributes to the literature on community perceptions of the benefits and barriers of
biobanking and adds to the development of meaningful education communication priming tools to
advance understandings about biobanking.
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Introduction
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Biobanks are repositories of human tissue (e.g., blood, urine, etc.), often connected to
electronic databases containing medical and personal health information, for the purposes of
diagnostic procedures, surgical treatment, and education or research [1, 2]. Biobanks are
envisioned as essential for effective basic, epidemiologic, and translational research. They
allow researchers to discover genetic associations of complex diseases and develop new
therapies and prevention strategies [3, 4]. To move closer to achieving goals related to
personalized medicine and individualized cancer care, participation in biobanking from large
numbers of diverse, multi-ethnic patients, in addition to healthy volunteers, is essential.
With the growth of biobanking, there is public concern over privacy issues, genetic
discrimination from employers and insurance providers, regulation of scientific research,
and compensation or other benefit from donated tissues [5, 6]. The National Cancer
Institute’s (NCI) Office of Biorepositories and Biospecimen Research identified the
development of educational communication priming tools and resources related to
biobanking as one of its strategic priorities [7]. To assuage the public’s concerns, the use of
community engagement methods to improve communications and understandings on
biobanking has been suggested by major health care institutions, such as the Mayo Clinic, as
one way to bring constituents’ voices into discussions and influence the way biobanks are
implemented [8–11]. In addition, accountability, transparency, and proper monitoring of
biobanking procedures are found to engender and maintain the public’s trust in biobanking
[12, 13].
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The theme of “therapeutic misconception” has emerged as an explanatory category for
possible egoistic motives for volunteering in clinical trials. In other words, some people
believe that participation in research might directly lead to a medical cure for either
themselves or their relatives [14, 15]. One study found that the type of tissue requested for
donation may affect the donor’s willingness to participate [5]. In qualitative research on
tumor tissue donation, responses from participants indicated that such tissue was “useless”
and better to be “thrown away,” or would just “go to waste” [16]. In a Swedish study,
varying rates of biobanking participation were shown to be a function of trust in one’s health
care provider, study investigator, or institution [17]. One recent study found that a
multipronged communication “strategy” with participants after receiving consent for
biobanking participation is a promising approach to enhance ‘trust’ in research, but that each
communication tool needs to be evaluated independently for effectiveness [18]. Other
motives might include a “gift exchange” or altruistic motives, wherein social ties are
reinforced between the giver and receiver of tissue, with the notion of future benefit for
either patients or science in general through the act of tissue donation [19]. An obvious
reason why healthy individuals may not participate in biobanking is lack of awareness or
knowledge of donation opportunities. Simply put, they may not have been aware that
donation is possible in certain clinical settings or even know what questions to ask about this
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topic. Additionally, some community members might initially refuse to participate in
biobanking because they have never considered the benefits of contributing to future
scientific research.
After donation, some participants may want assurances that their samples will be handled
responsibly. One study found that individuals are more likely to participate in biobanking if
they could maintain some control and monitoring over their biospecimens, preferring
categorical versus blanket informed consent for use of their samples [20]. This position
however is problematic for researchers since future technological advances cannot always be
predicted, and consequently, donors may be unable to meaningfully engage in an informed
consent process which requires future decisions about the use of their tissue samples [21].
Other studies suggest that many individuals have found participants do not feel the need to
understand all the study details to participate in biobanking. Rather, they feel relatively
confident in the merits of scientific research [5, 22]. A systematic review reported that
participants who refused consent were often more concerned with the method for obtaining
the tissue (e.g., blood draw, biopsy) than with the possible use of their samples for research
[23].

NIH-PA Author Manuscript

Preparing healthy community members with timely communications prior to engaging them
in a request promises to improve the experience of biobanking participation, as people will
have an opportunity to understand the topic and make an informed decision. Attention to
health literacy and specific cultural and linguistic needs of multi-ethnic populations when
creating biobanking communications are integral to meaningfully address proximal
decisional determinants [24]. Moreover, from a researcher’s perspective, there is a strong
need for donors as healthy controls for epidemiological studies.
Thus, a qualitative study was undertaken to assess community member knowledge, attitudes,
beliefs, and informational needs about biobanking, in response to the establishment of a
biobank in Tampa Bay, Florida. This study was conducted as part of the NCI-funded Tampa
Bay Community Cancer Network (TBCCN), which is one of the Community Network
Program sites composed of 22 partner organizations and tasked with the goal of reducing
cancer health disparities among racial/ethnic minority and medically underserved
populations. This study gauges how to best frame information in advance of opportunities
for community donation to a local biobank, such as with Moffitt’s Cancer Center’s Total
Cancer Care plan, which combines information technology, science, and clinical treatment
[25]. Findings may also have implications for other regional and national biobanking
initiatives seeking to include participation of community members as healthy controls.

NIH-PA Author Manuscript

Methods
Design
Twelve focus groups were conducted to explore knowledge, attitudes, beliefs, and
informational needs regarding biobanking with healthy community members.
Community Advisory Group
The study was conducted with the guidance of a biobanking community advisory group
(CAG). Members from the CAG were identified from the TBCCN partner organizations.
The advisory group members guided study efforts by ensuring the study design and
instruments had relevance and meaning for community members. The CAG met quarterly to
review study instruments, examine focus group questions, evaluate the promotional
materials, and provide important community insights and perspectives. Interactive activities
to engage advisory group members included educational presentations and a tour of
biobanking facilities. The study was conducted under the auspices of the TBCCN cancer
J Cancer Educ. Author manuscript; available in PMC 2013 August 06.
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Sampling and Recruitment
The number of groups was determined by three preidentified age and sociodemographic
segments, based on the principle of thematic saturation [26]. The groups were segmented by:
(1) race/ethnicity and language (mixed race; African American only and Spanish speaking)
and (2) age group (18–29, 30–54, and 55 and older). Groups were segmented based on
potential differences that were previously found from studies on cancer-related knowledge
with diverse populations in Tampa Bay [27, 28]. The sample included six mixed race, three
African American, and three Spanish-speaking focus groups, and the focus groups ranged in
size from four to 11 people (Table 1).
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The study utilized purposive sampling techniques to recruit a total of 95 participants.
Eligibility criteria for participation in the focus groups included individuals who were: (1)
able to speak English or Spanish; (2) ≥18 years of age; and (3) not previously diagnosed
with cancer other than non-melanoma skin cancer. Recruitment was facilitated through
collaborations with existing community networks and the CAG. Recruitment flyers were
disseminated at community partner sites and through word of mouth using outreach workers,
community leaders, and health educators. Research personnel screened interested
individuals for eligibility over the phone. Eligible individuals were then invited to
participate in one of the focus groups, which lasted approximately 2 h.
Instrumentation and Data Collection
A semi-structured focus group guide was developed through a review of existing literature
and with feedback from the CAG members and lead investigators who helped shape the
following domains for exploration: (1) general health and research knowledge and attitudes;
(2) knowledge, attitudes, and beliefs towards biospecimen collection; (3) motivations toward
research and biospecimen collection and informational needs; (4) ethical concerns regarding
biospecimen collection; and (5) learning preferences [5, 29, 30]. A brief sociodemographic
survey was used to collect participant’s age, race/ethnicity, gender, marital status, highest
educational level attainment, occupation, and employment status. All instruments were
professionally translated by a certified translator for the Spanish language focus groups. The
general purpose of the focus groups was to explore community members’ knowledge,
attitudes, and beliefs toward cancer-related biospecimen collection/biobanking [31].

NIH-PA Author Manuscript

Focus groups were conducted at various community sites by pairs of trained focus group
moderators, in either English or Spanish depending on the language preference of the group.
All participants provided informed consent prior to the focus group. Light refreshments were
served. At the beginning of each focus group, the moderator provided a definition of the
term “biobank” and explained its function. After each focus group, participants completed a
brief demographic questionnaire. In our study, we discovered that no new themes were
identified after five focus groups; however, based on our sampling strategy of having three
groups per demographic composition (to identify possible differences), we continued to
conduct the groups until we had completed our original sampling strategy. This study was
approved by the university institutional review board, and participants received a $30 cash
stipend.
Qualitative Data Coding and Analysis
Focus groups were digitally recorded, transcribed verbatim, manually coded, and reviewed
by members of the research team. Grounded Theory, a content analysis technique, was used
to identify emergent themes, or trends from the focus group transcripts [32]. The coding
J Cancer Educ. Author manuscript; available in PMC 2013 August 06.
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procedures followed a series of steps which included: (1) developing a preliminary set of
codes (themes) corresponding to each item in the interview protocol, (2) creating additional
codes that emerged and were of special interest to the research goals, (3) developing nonsubstantive codes, and (4) producing detailed codes to use for analyses of specific topics.
MAXQDA [33], a computer-assisted qualitative data analysis software was used to facilitate
the coding process. The software package enabled pairs of coders to work collaboratively
across transcripts on each theme. Each theme was assessed in terms of its implications for
developing educational communication priming tools on biobanking. Sociodemographic
information of focus group participants was summarized using descriptive statistics,
including means, standard deviations, and frequencies.

Results
Knowledge of Genetics, Biobanks, and Terminology
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Focus group participants reported their sources of health information primarily came from
the internet (e.g., WebMD and Wikipedia), television, or personal contact with health
professionals. There was limited prior genetic knowledge among all participants.
Participants most frequently mentioned genetic research in relation to stem cells and
Alzheimer’s disease. In one of the African American focus groups, participants expressed
mistrust of research because of the perception that scientific recommendations were
constantly changing, and the ethical issues raised with animal testing. Tied to this idea of
how research was typically conducted was the perception that research depersonalized
disease processes. Using cancer as an example, one participant said, “When we are talking
about this research, and any human being … to donate for research. To me, it should be
more PERSONALIZED in the sense of some cancers affect some people, and the same
circumstances don’t affect other people. So, in my opinion … I kind of feel like the research
is time wasted.” (30–54 years, female).
Another common association elicited in the groups was the relationship between genetics
and DNA with paternity testing, criminal investigations, and hereditary diseases. Six of the
12 groups mentioned the role of genetics as a determinant of cancer (i.e., BRCA 1 or 2), and
the unrelated recent controversy about changing breast cancer screening guidelines by the
US Preventive Services Task Force for increasing the initial recommended screening age
from 40 to 50 years [34].

NIH-PA Author Manuscript

After a brief definition of biobanking, the focus group moderators asked participants to
share their knowledge and suggest alternative terms to describe the term biobanking. In four
of the 12 groups, there was limited knowledge or awareness of biobanking. For example in
one of the groups, participants asked, “How do they store it? Do they freeze it?” (18–29
years, male). Participants in another group believed that biospecimen collection was already
being conducted with de-identified leftover tissue. Other participants in the same group
suspected that this tissue might be shipped to other countries without “strict laws” governing
research, as in the USA. Another group also expressed mistrust of donated tissue for
possible deceptive research purposes. In two of the groups, there was the association of
sperm, blood, and umbilical cord banking with biobanking. Of the four groups with
biobanking knowledge, possible alternative terms for biobanks included, biolibrary,
biostorage, and biodatabase. The three Spanish language groups used possible alternative
terms such as biblioteca (library), bodega (storage warehouse), and banco de células (cell
bank), as described by one participant, “I would call it storage because we will have
everything [in it], and because we will have everything [in it] we will discover everything
[from it].” (30–54 years, female). In general, the word biobank was an acceptable term
despite its obvious association with financial institutions.

J Cancer Educ. Author manuscript; available in PMC 2013 August 06.
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Perceived benefits to participation in biobanking included having a family history of chronic
disease (e.g., family member with cancer and perceived future therapeutic benefit of
contributing to research), convenience (e.g., already having a procedure done and donating
tissue), immediate benefits to someone else (e.g., donating blood or bone marrow), receiving
cash incentives, and a general sense of helping society and future generations (Table 2). One
sentiment of benefiting future generations was described: “So for all those millions out there
that got all those children, they are sitting there watching them die… that purpose alone
would make me, because they deserve a fair chance, just for the children.” (30–54 years,
female).

NIH-PA Author Manuscript

Having positive relationships with a healthcare provider was reported as increasing one’s
motivation to donate. In one African American group, there was mention that one would
donate in exchange for payment for urine and saliva samples, but not for blood. In one of the
mixed race groups, a participant stated, “as long as the doctors performing it give you an
explanation why, and what it’s going to do, how it’s going to be a benefit to maybe yourself
or another individual, then I’d have no problem.” (55+ years, male). Finally, some
participants did not feel strongly about the topic, explaining that they did not need to know
all the specifics of studies as explained in informed consent documents, and that leftover
tissue from medical procedures was disposable and not of profound importance, as one
participant expressed, “It’s already out, they’ll throw it out anyway.” (18–29 years, male).
Perceived Barriers
Perceived barriers for biobanking participation included fear of biospecimen extraction
procedures (e.g., needles or repetitive blood draws), cloning concerns (e.g., research
misconduct or bioweapons development), and lack of information about how biobanks
functioned (e.g., biospecimen extraction and storage procedures or access to the data).
Moreover, there was mistrust of researchers (e.g., lack of transparency or potential
exploitation of research subjects for profit), as well as privacy concerns (e.g., insurance
companies using information in determining coverage, disclosure of personal health history,
or vulnerable computer database systems). For example, one participant said, “I wonder
about the security of the actual physical storage place. I don’t want people breaking in the
place.” (18– 29 years, male).

NIH-PA Author Manuscript

Media coverage on the Henrietta Lacks story and HeLa cells, prompted by the publication of
a popular book, was directly mentioned in one focus group, and alluded to in two other
focus groups, thus contributing to negative perceptions toward the use of biospecimens [35].
In two of the African American groups, there was the view that research was conducted for
the benefit of white populations, while minority groups have been unjustly used as “lab rats”
or “guinea pigs.” In one of these groups, participants felt that doctors were more concerned
with research than caring for their patients. Moreover, questions were raised relating to the
direct benefits stemming from biomedical research participation, as one participant stated:
“if your cells DO become useful, whose are they, and do you benefit from them? So, I think
that would be my concern … there’s a collection of cells from us … okay, this could be
beneficial to generations after us, but we won’t actually ever see it. Maybe in the future
we’ll see it, and so there’s not really a DIRECT BENEFIT to it; but I think there are still a
lot of questions.” (18–29 years, female).
Similarities and Differences by Age Group in Biobanking Perceptions
Across all age groups, those who had a family member diagnosed with cancer were more
willing to consider participation and to donate to help others to advance scientific research.
This theme was expressed by one participant in one of the African American groups, “I have
J Cancer Educ. Author manuscript; available in PMC 2013 August 06.
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had members of my family die of cancer, and so anything I can do to be of assistance as far
as education and research.” (30–54 years, female). However, participants in the youngest
age group expressed more concerns about privacy, confidentiality, and mistrust of the use
for their biospecimens: “In order to [donate], I would have to REALLY research that
company. I would want to know where … what they are doing, how they are going to do it,
everything!” (18–29 years, female). Participants in the two other groups (30–54 and 55+)
voiced some mistrust in medical research, the validity of consent forms, and the ability to
withdraw consent; however, they were more willing to donate than the youngest age group
for the benefit of science, as stated by one participant, “I will give you anything you want—
blood, whatever you want—if you find a cure.” (30–54 years, male).
Promotion Types and Content of Messages
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There was a wide variation of traditional and nontraditional promotion channels, content,
and messengers discussed in the focus groups. In particular, the 18–29-year group
mentioned social media while the other groups suggested television news programs and talk
shows. Across all age groups, participants referred to the use of health fairs, workshops, and
physician’s offices as appropriate places for dissemination of pamphlets and exposure to
video content. In one of the Spanish-speaking groups, the suggestion was made to involve
community members in the dissemination of biobanking information and to use a workshop
format so potential participants could have their questions answered. Two of the focus
groups, one Spanish-speaking group and one group composed of predominately women 55+,
mentioned the use of photo-novellas. For messengers, doctors and sports celebrities were
identified as the most common spokespersons. In one example, a conversation between a
doctor and a patient was discussed, wherein the doctor would explain in a serious tone the
importance of obtaining biospecimens for research purposes to a well-known celebrity
acting as a patient. In sum, most participants wanted to learn about biospecimen donation
from a credible (physician) or familiar (sports celebrity) source, and in an easy-tounderstand, entertaining, and engaging manner.
Regarding message content, a number of groups expressed concerns about blanket consent
for the use of their tissue because they would not benefit financially if new cures or
discoveries were to result. Also, participants wanted information related to the steps
involved with biobanking and an explanation of the commitment required for participants.
Moreover, participants felt consent issues should be addressed sufficiently in terms of ethics,
ownership, access to their biospecimens, and specific tests to be undertaken.

Discussion
NIH-PA Author Manuscript

The development of novel cancer therapies tailored to an individual’s genetic profile is the
promise of personalized medicine [36]. Biobanks provide the resources for a robust database
for future scientific advances in biomolecular and bioinformatics technology. Yet, to realize
these scientific activities, it is necessary to earn the public’s trust to ensure donation of
biospecimens from willing and well-informed participants. Formative research can aid in
this endeavor by identifying beliefs and attitudes toward cancer-related biobanking and
inform the production of educational communication priming tools to address the learning
needs and concerns of diverse audiences. A key finding was that participants wanted to learn
about biospecimen donation from a credible source, and in an easy-to-understand,
entertaining, and engaging manner.
We chose an exploratory, qualitative methodological approach since there is little known
about the opinions of healthy volunteers in the USA toward participation in biobanking. We
stratified groups by age, race/ethnicity, and language preference to allow us to discern
differences by these sociodemographic characteristics. Generational differences were most
J Cancer Educ. Author manuscript; available in PMC 2013 August 06.
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pronounced. Among focus group participants in the youngest age group (18–29 years),
mistrust was expressed toward biomedical research and the government in general terms. In
two of these focus groups (one mixed race, one Hispanic), the topics of the Tuskegee and
Guatemala syphilis experiments and the HeLa cell line were discussed as examples of
mistrust in research and why more education was needed to convince potential biobanking
donors to participate [37, 38]. Moreover, in the 18–29-year age groups, monetary incentives
in exchange for biobanking participation were indicated as a necessary tradeoff for
participation, despite elevated privacy concerns and worries about exploitation. Comparison
of focus group themes did not reveal obvious differences based on group stratification by
race/ethnicity or language preference.

NIH-PA Author Manuscript

One salient theme from our results is that most people choose to donate based on their life
histories, experiences, and perceptions of the costs and benefits [5]. Less important perhaps
are the specific details of how their information will be kept or used in future research
studies if they make the determination that donating will provide a benefit which is greater
than the limited cost of imaginary negative outcomes (e.g., cloning). More important
barriers might be related to actual fears people have of needles or other intrusive methods
which could cause them discomfort in the process of tissue donation. Results showed people
will be more motivated to donate tissue if they have had a personal experience of a family
member affected by cancer or hold a favorable view toward the intrinsic merits of scientific
or medical research.
Issues concerning privacy and mistrust of research reported in US biobanking studies appear
to be less salient issues in European biobanking studies [39, 40]. In a US study, the
researchers found that privacy concerns were paramount for many prospective participants,
and could be a primary reason for withdrawing from a research study [41]. On the other
hand, a large survey of biobank donors in Sweden found that fewer than two thirds recalled
consenting to donate a blood sample and less than 6% felt unsatisfied with the study
information they had received in the process [22]. The study found that donors may be
overloaded with written information in the informed consent document that they do not
necessarily need to read or fully understand to make a decision. The decision to donate
tissue may actually be a low-risk decision for many in terms of privacy concerns or other
worries, such as not receiving research results, having future studies conducted with their
tissues, or not sharing in future profits from scientific discoveries [41].
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Once people decide to donate biospecimens—either for altruistic reasons, to save someone
else’s loved one, or to benefit science—they can become subsequently detached from the
donated tissue, thinking of it as “disposable,” or perhaps recyclable, as expressed by the
participant who said the “thrown out” tissue might as well be used for something. Donors of
healthy tissue may become disassociated from the tissue, and consequently, the expectation
of a personal benefit from the exchange relationship is diminished. This stands in sharp
contrast to the experience of organ donors who have sacrificed tissue imbued with
“sacredness” and a higher intrinsic value; therefore, organ donor recipients often feel
emotionally motivated to reciprocate the gift in some fashion [19].
This qualitative study has certain limitations. While we were successful in recruiting a
diverse sample for the focus group discussions, our research participants lived in a large
metropolitan area in southwest Florida. Particular sociodemographic characteristics of the
participants from this region may have influenced responses to our questions, so similar
research conducted in other parts of the USA near academic medical centers may produce
different results.

J Cancer Educ. Author manuscript; available in PMC 2013 August 06.
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This study contributes to the literature on community opinions of knowledge, attitudes, and
beliefs toward biobanking and offers direction for researchers seeking to engage community
members in biospecimen collection for disease-focused protocols and for recruitment of
healthy controls. The focus group results contributed to the design of a creative brief and
communication strategies to effectively frame biobanking educational content for print and
visual media, with attention to health literacy and cultural competency [24]. Our next steps
entail developing educational communication priming tools (English and Spanish versions)
customized to community member’s learning preferences, expectations, and literacy levels.
These tools will be designed to primarily reach the 30+ age groups since they are most
similar in their perceptions and attitudes about biobanking participation, and in their
communication preferences (e.g., DVD/booklet). We feel that separate educational tools that
address the concerns of the younger group (age 18–29) and delivered in a social media
format may be warranted. In addition, focus group data contribute to the development of
scales designed to measure attitudes toward biospecimen donation and biobanking,
knowledge regarding biospecimen donation and biobanking, self-efficacy for making the
decision to donate specimens to a biobank, and intention to donate specimens to a biobank.
Taken together, findings and tools from these studies will inform education efforts,
recruitment and participation of community members in behavioral, epidemiologic, and
other biomedical research involving biobanking. Future studies are expected to test the
efficacy of these tools for decision priming.

NIH-PA Author Manuscript
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Table 1

Characteristics of focus group participants (N=95)
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n (%)

Characteristics
Age group (years)
18–29

31 (32.6)

30–54

34 (35.8)

55+

30 (31.6)

Sex
Female

65 (68.4)

Male

30 (31.6)

Race
American Indian/Alaska native
Asian

3 (3.2)
1 (1.0)

Black/African American

33 (34.7)

White

36 (37.9)

Other

17 (17.9)

NIH-PA Author Manuscript

No answer

5 (5.3)

Spanish speaking
Yes

37 (38.9)

No

56 (59.0)

No answer

2 (2.1)

NIH-PA Author Manuscript
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Table 2

Representative responses grouped by thematic and topical categories

NIH-PA Author Manuscript

Theme/topic

Illustrative quotes

Barriers
Fear of needles

“I think like, as far as like the blood … if they ask me right when I’m giving it, and it’s not going to
endanger me, I don’t care. But, if they are going to poke me again, I don’t know about that.” (18–29-year
female; mixed race, mixed gender group)
“Or ‘needle friendly.’ It just, you know, you think of what type of specimen do they need? If it’s blood, if it’s
needles, if you need to cut something out, you know.” (30–54-year female, mixed race; mixed gender group)
“It conjures up images of giving blood, and not all of us are needle worthy.” (55+-year female; mixed race,
mixed gender group)

NIH-PA Author Manuscript

Privacy concerns

“I wonder about the security of the actual physical storage place. I don’t want people breaking in the
place.” (18–29-year male; mixed race, mixed gender group)

Lack of information

In reference to informed consent protocols, “It doesn’t matter. Like, if you want to be really specific and
you want to tell me, then that’s fine. But I don’t really need to know.” (18–29-year male; African
American, mixed gender group)

Mistrust of researchers

“They ask me for samples then, and they explain everything to me. And then, let’s say that I go to another,
like another hospital or somewhere else, and I happen to know that they sell their, you know, their
samples for a ridiculous price to other people. I think it matters on the situation. Or whether they want,
like, two tubes of blood to like a whole pint of blood. Like you were saying, we want to know pros and
cons for every situation.” (18–29-year female; mixed race, mixed gender group)

Generational or religious
factors

“Me, personally, I had looked into like um, a donation because I think it would be a beneficial thing for a
family or something, and my mom was against me going for it. And to her, you know, it’s kind of like a
cultural religious shock, but I didn’t personally have that kind of, um, that personal view. Yeah, it didn’t
really like factor into my thought process behind making that decision. But for her it did. I think it kind
of just depends on how you perceive, know where your donation is going and what benefit it will have.”
(18–29-year female; African American, mixed gender group)

Lack of cash remuneration

Benefits
Family history as motivator
Convenience

“You know, like oh, well, this person you gave her the donation, but we are charging them $3,000, $4,000,
X amount of dollars so that they can have it, and I wouldn’t really want to agree with that.” (18–29-year
female; mixed race, mixed gender group)
“My sister just died from cancer … I’d give up a finger right now if it would help.”
“I have had members of my family die of cancer, and so anything I can do to be of assistance as far as
education and research.” (18–29-year female; African American, mixed gender group)
“It’s already out; they’ll throw it out anyway.” (18–29-year; mixed race, mixed gender)

Immediate benefits to
someone else

“I will give you anything you want—blood, whatever you want—if you find a cure.” (30–54-year male;
mixed race, mixed gender group)

Helping science or society

“So for all those millions out there that got all those children, they are sitting there watching them die…
that purpose ALONE would make me, because THEY DESERVE a fair chance, just for the children.”
(30–54-year female; mixed race, mixed gender group)

Positive relationships with a
healthcare provider

“As long as the doctors performing it give you an explanation why, and what it’s going to do, how it’s
going to be a benefit to maybe yourself or another individual, then I’d have no problem.” (55+-year
male; mixed race, mixed gender group)

Message content
Informed consent
information

NIH-PA Author Manuscript

“In the consent form that I sign saying hey yeah, I give you authorization to do this, it should be stated
maybe in the consent form that do you give us permission to test for other things in the future with this
current sample.” (30–54-year male; mixed race, mixed gender group)
“I might question though—even if I do have an informed consent and I do agree to it, and my specimens
are used somewhere else—I have no way to, I maybe will have no way to track how my samples were
being used. And so this contract—this legal contract—doesn’t really mean anything because I have no
way to track how it’s being used anyhow.” (18–29-year female; mixed race, mixed gender group)
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